Editor’s Choice Paper: Identifying safe diagnostic algorithms for sentinel lymph node mapping in high-risk endometrial cancer: The SENTIREC-endo study Editorial: Sentinel lymph node biopsy in high-risk endometrial cancer: The dénouement Hosted by: Gregg Nelson, MD, Social Media Editor of Gynecologic Oncology Featuring: Sarah M. Bjørnholt, MD, Aarhus University Hospital, Denmark Sean Dowdy, MD, Mayo Clinic, USA

Editor’s Choice Paper:  Experiences of patients with peritoneal carcinomatosis-related complex care needs and their caregivers Editorial: The importance of family-focused care in the setting of advanced gynecological cancers Hosted by: Sean Dowdy, MD, Associate Editor of Gynecologic Oncology Featuring: Rachel A. Pozzar, PhD, RN, Dana Farber Cancer Institute and Harvard Medical School Allison J. Applebaum, PhD, Caregivers Clinic, Memorial Sloan Kettering Cancer Center

Editor’s Choice Paper:  Lunchbox trial: A randomized phase III trial of cisplatin and irradiation followed by carboplatin and paclitaxel versus sandwich therapy of carboplatin and paclitaxel followed by irradiation then carboplatin and paclitaxel for advanced endometrial carcinoma Editorial: What's in your “lunchbox”? Sandwich versus sequential chemotherapy and irradiation for advanced endometrial cancer Hosted by: Ursula Matulonis, MD, Associate Editor of Gynecologic...

Editor’s Choice Paper:  Overall survival and patient-reported outcome results from the placebo-controlled randomized phase III IMagyn050/GOG 3015/ENGOT-OV39 trial of atezolizumab for newly diagnosed stage III/IV ovarian cancer Hosted by: Ursula Matulonis, MD, Associate Editor of Gynecologic Oncology Featuring: Kathleen N. Moore, MD, GOG-F and Stephenson Cancer Center at the University of Oklahoma Health Sciences Center 

Editor’s Choice Paper:  Incidence of venous thromboembolism in patients with advanced stage ovarian cancer undergoing neoadjuvant chemotherapy: Is it time for thromboprophylaxis? Editorial: Universal thromboprophylaxis in ovarian cancer patients before and after surgery? Hosted by: David E. Cohn, MD, MBA, FACHE, Editor-in-Chief of Gynecologic Oncology Featuring: Amanika Kumar, MD, Mayo Clinic  Laura Havrilesky, MD, Duke University 

Editor's Choice Paper: Incidence of venous thromboembolism in patients with advanced stage ovarian cancer undergoing neoadjuvant chemotherapy: Is it time for thromboprophylaxis? Editorial:Universal thromboprophylaxis in ovarian cancer patients before and after surgery? Hosted by: David E. Cohn, MD, MBA, FACHE, Editor-in-Chief of Gynecologic Oncology Featuring: Amanika Kumar, MD, Mayo Clinic Laura Havrilesky, MD, Duke University

Hosted by: S. Diane Yamada, MD, Deputy Editor of Gynecologic Oncology Featuring: Maaike Oonk, MD, University Medical Center Groningen, University of Groningen, The Netherlands Akila Viswanathan, MD, MPH, Johns Hopkins Medicine Editor’s Choice Paper: Unilateral inguinofemoral lymphadenectomy in patients with early-stage vulvar squamous cell carcinoma and a unilateral metastatic sentinel lymph node is safe Editorial: When is it safe to omit contralateral groin management in unilateral...

Hosted by: Gregg Nelson, MD, PhD, Social Media Editor of Gynecologic Oncology Featuring: Brittany A. Davidson, MD, Duke University David M. Kushner, MD, UW School of Medicine and Public Health Article: SGO and the elephant that is still in the room: Wellness, burnout and gynecologic oncology

Moderator: Leslie Clark, MD, Gynecologic Oncologist, University of North Carolina in Chapel Hill Speakers: Róisín O’Cearbhaill, MD, Medical Oncologist, Memorial Sloan Kettering Cancer Center Ramez Eskander, MD, Gynecologic Oncologist, University of California San Diego Description: Dr. Leslie Clark presents a patient case to frame a discussion on the management of immunotherapy-related toxicities in gynecologic cancers. Drs. Róisín O’Cearbhaill and Ramez Eskander provide...

Hosted by: Jose Alejandro Rauh-Hain, MD, MPH, Associate Editor of Gynecologic Oncology Featuring: Steven S. Coughlin, MD, Augusta University Daniel Addison, MD, The Ohio State University Wexner Medical Center Editor’s Choice Paper: Cardiovascular conditions and obesity among gynecologic cancer survivors: Results from the 2020 behavioral risk factor surveillance system survey Editorial: The intersection of gynecologic cancer, obesity, and cardiovascular disease

Editor’s Choice Papers:  What's in it for me?: A value assessment of gynecologic cancer clinical trials for Black women Editorial:  Achieving diversity in clinical trial enrollment by reducing burden and increasing value: A patient-centered approach Hosted by: Ursula Matulonis, MD, Associate Editor of Gynecologic Oncology Featuring: Ann Oluloro, MD, MPH, University of Washington Eloise Chapman-Davis, MD, Weill Cornell Medicine        

Hosted by: Amanda Nickles Fader, MD, Associate Editor of Gynecologic Oncology Featuring: David M. Gershenson, MD, The University of Texas MD Anderson Cancer Center Charlie Gourley, MD, Nicola Murray Centre for Ovarian Cancer Research Editor’s Choice Paper: Contemporary primary treatment of women with stage II-IV low-grade serous ovarian/peritoneal cancer (LGSOC): Determinants of relapse and disease-free survival Editorial: Low grade serous ovarian cancer: Unpicking drivers of outcome

Hosted by: Gregg Nelson, MD, PhD, Social Media Editor of Gynecologic Oncology Featuring: Mariam M. AlHilli, MD Gynecologic Oncologist, Cleveland Clinic, Cleveland, Ohio Amanika Kumar, MD, Mayo Clinic Division of Gynecologic Surgery, Rochester, Minnesota Editor’s Choice Paper: Preoperative assessment using the five-factor modified frailty index: A call for standardized preoperative assessment and prehabilitation services in gynecologic oncology Editorial: Answering the call: Are...

Editor’s Choice Papers:  Improving genetic testing following abnormal mismatch repair immunohistochemistry results in endometrial cancer Editorial: Universal testing – Should it be that hard? Probably. If you're doing it right Hosted by: Gregg Nelson, MD, PhD, Social Media Editor of Gynecologic Oncology Featuring: Bhavana Pothuri, MD,NYU Perlmutter Cancer Center Leigha Senter, MS, CGC, The Ohio State University College of Medicine

Hosted by: Ursula Matulonis, MD, Associate Editor of Gynecologic Oncology and Author of the editorial Featuring: David O'Malley, MD, The Ohio State University Editor’s Choice Paper: Clinical and molecular characteristics of ARIEL3 patients who derived exceptional benefit from rucaparib maintenance treatment for high-grade ovarian carcinoma Editorial: The rapid evolution of PARP inhibitor therapy for advanced ovarian cancer: Lessons being learned and new questions emerging from...

Host: Barbara Goff: Deputy Editor, Gynecologic Oncology and Gynecologic Oncology Reports Featuring: Sabrina Ford & Sandra Brooks

Hosted by: John Farley, MD, Associate Editor of Gynecologic Oncology Featuring: Catherine H. Watson, MD, Vanderbilt University Medical Center Larissa Alejandra Meyer, MD MPH, The University of Texas MD Anderson Cancer Center Editor’s Choice Paper: Reducing non-surgical readmissions on a gynecologic oncology service Editorial: Our dual responsibility of improving quality and questioning the metrics: Reflections on 30-day readmission rate as a quality indicator

Hosted by: Gregg Nelson, MD, PhD, Social Media Editor of Gynecologic Oncology Featuring: Brittany A. Davidson, MD, Duke University David M. Kushner, MD, UW School of Medicine and Public Health Article: SGO and the elephant that is still in the room: Wellness, burnout and gynecologic oncology

Moderator:  Floor Backes, MD, Gynecologic Oncologist, The Ohio State University Comprehensive Cancer Center Speakers: Vicky Makker, MD, Medical Oncologist, Memorial Sloan Kettering Cancer Center Matthew Powell, MD, Gynecologic Oncologist and Chief, Division of Gynecologic Oncology, Washington University School of Medicine Siteman Cancer Center Amanda Nickles Fader, MD, Gynecologic Oncologist and Professor, Johns Hopkins School of Medicine  Description: Dr. Floor Backes is...

Hosted by:  Warner K. Huh, MD, FACOG, FACS, Deputy Editor of Gynecologic Oncology Featuring: Elizabeth Swisher, MD, UW Medicine Jonathan A Ledermann, MD FRCP FMedSci Professor of Medical Oncology, UCL Cancer Institute Editor’s Choice Paper: Impact of homologous recombination status and responses with veliparib combined with first-line chemotherapy in ovarian cancer in the Phase 3 VELIA/GOG-3005 study Editorial: Testing for homologous recombination deficiency – does it provide...

Hosted by: Wendy R. Brewster, MD, PhD, Deputy Editor of Gynecologic Oncology Featuring: Turgay Ayer, Georgia Institute of Technology Tara Castellano, MD, Louisiana State University HSC Isabel C. Scarinci, PhD, MPH, University of Alabama at Birmingham Editor’s Choice Paper: Cervical cancer geographical burden analyzer: An interactive, open-access tool for understanding geographical disease burden in patients with recurrent or metastatic cervical cancer Editorial: Targeting our...